Search research articles
Contact Us
Filters
Showing results (231-240 of 270) with videos related to
Page
of 27
Sort By:
JAMA Cardiology
|
November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Douglas L Mann, Michael M Givertz, Justin M Vader, et al.
JAMA Cardiology
|
March 17, 2021
Metabolic Cost of Exercise Initiation in Patients With Heart Failure With Preserved Ejection Fraction vs Community-Dwelling Adults
Ravi V Shah, Mark W Schoenike, Miguel Á Armengol de la Hoz, et al.
JAMA
|
May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial
Gregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
European Journal of Heart Failure
|
May 1, 2021
Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings
Sara Hadzibegovic, Alessia Lena, Timothy W Churchill, et al.
Circulation
|
April 13, 2012
Metabolite profiling identifies pathways associated with metabolic risk in humans
Susan Cheng, Eugene P Rhee, Martin G Larson, et al.
JACC. Cardiovascular Interventions
|
April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study
Alexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
JACC. Heart Failure
|
July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
Douglas L Mann, Stephen J Greene, Michael M Givertz, et al.
Journal of the American College of Cardiology
|
September 1, 2024
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Charles F Sherrod, Sara Saberi, Michael E Nassif, et al.
Circulation
|
September 5, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial
Joseph Campain, Catharine Griskowitz, Chloe Newlands, et al.
JAMA Internal Medicine
|
December 1, 2015
Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Ravi V Shah, Venkatesh L Murthy, Laura A Colangelo, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 270) with videos related to
Sort By:
Page
of 27
JAMA Cardiology
|
November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Douglas L Mann, Michael M Givertz, Justin M Vader, et al.
JAMA Cardiology
|
March 17, 2021
Metabolic Cost of Exercise Initiation in Patients With Heart Failure With Preserved Ejection Fraction vs Community-Dwelling Adults
Ravi V Shah, Mark W Schoenike, Miguel Á Armengol de la Hoz, et al.
JAMA
|
May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial
Gregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
European Journal of Heart Failure
|
May 1, 2021
Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings
Sara Hadzibegovic, Alessia Lena, Timothy W Churchill, et al.
Circulation
|
April 13, 2012
Metabolite profiling identifies pathways associated with metabolic risk in humans
Susan Cheng, Eugene P Rhee, Martin G Larson, et al.
JACC. Cardiovascular Interventions
|
April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study
Alexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
JACC. Heart Failure
|
July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
Douglas L Mann, Stephen J Greene, Michael M Givertz, et al.
Journal of the American College of Cardiology
|
September 1, 2024
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Charles F Sherrod, Sara Saberi, Michael E Nassif, et al.
Circulation
|
September 5, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial
Joseph Campain, Catharine Griskowitz, Chloe Newlands, et al.
JAMA Internal Medicine
|
December 1, 2015
Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Ravi V Shah, Venkatesh L Murthy, Laura A Colangelo, et al.
Page
of 27